Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

NOVAVAX INC Director's Dealing 2025

Mar 12, 2025

31982_dirs_2025-03-12_2a2d2528-7a2b-4641-be91-2673d5070c34.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2025-03-10

Reporting Person: Shiver John W. (Director)

More from NOVAVAX INC

Regulatory Filings 2026
May 6
Interim / Quarterly Report 2026
May 6
Annual Report 2026
Apr 27
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Director's Dealing 2026
Mar 3
Regulatory Filings 2026
Feb 26
Annual Report 2026
Feb 26
Director's Dealing 2026
Jan 26
View all filings →